Clinical Trials
7
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)โข Click on a phase to view related trials
Response to an Investigational Device in Patients With Restless Legs Syndrome
- Conditions
- Restless Legs Syndrome
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Noctrix Health, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06866132
- Locations
- ๐บ๐ธ
Noctrix Health Headquarters, Pleasanton, California, United States
A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS
- Conditions
- Restless Legs Syndrome
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- Noctrix Health, Inc.
- Target Recruit Count
- 325
- Registration Number
- NCT06076499
- Locations
- ๐บ๐ธ
Mark J Buchfuhrer, MD Office, Downey, California, United States
๐บ๐ธSleep Medicine Specialists of California, San Ramon, California, United States
๐บ๐ธNeurocare, Inc., Newton, Massachusetts, United States
Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS
- Conditions
- Restless Legs Syndrome
- First Posted Date
- 2022-01-31
- Last Posted Date
- 2023-12-15
- Lead Sponsor
- Noctrix Health, Inc.
- Target Recruit Count
- 58
- Registration Number
- NCT05214963
- Locations
- ๐บ๐ธ
SRI International Human Sleep Research Lab, Menlo Park, California, United States
๐บ๐ธSleep Medicine Specialists of California, San Ramon, California, United States
๐บ๐ธClayton Sleep Institute, Saint Louis, Missouri, United States
Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS
- Conditions
- Restless Legs Syndrome
- First Posted Date
- 2022-01-19
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- Noctrix Health, Inc.
- Target Recruit Count
- 101
- Registration Number
- NCT05196828
- Locations
- ๐บ๐ธ
California Center for Sleep Disorders, San Leandro, California, United States
๐บ๐ธDelta Waves, Inc., Colorado Springs, Colorado, United States
๐บ๐ธNeurotrials Research, Atlanta, Georgia, United States
Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)
- Conditions
- Restless Legs Syndrome
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Noctrix Health, Inc.
- Target Recruit Count
- 133
- Registration Number
- NCT04874155
- Locations
- ๐บ๐ธ
California Center for Sleep Disorders, San Leandro, California, United States
๐บ๐ธDelta Waves, Inc., Colorado Springs, Colorado, United States
๐บ๐ธNeurotrials Research, Atlanta, Georgia, United States
- Prev
- 1
- 2
- Next